195 related articles for article (PubMed ID: 24304617)
21. Clinicopathologic significance of the expression of Snail in hepatocellular carcinoma.
Woo HY; Min AL; Choi JY; Bae SH; Yoon SK; Jung CK
Korean J Hepatol; 2011 Mar; 17(1):12-8. PubMed ID: 21494073
[TBL] [Abstract][Full Text] [Related]
22. T-box Transcription Factor Tbx3 Contributes to Human Hepatocellular Carcinoma Cell Migration and Invasion by Repressing E-Cadherin Expression.
Feng X; Yao W; Zhang Z; Yuan F; Liang L; Zhou J; Liu S; Song J
Oncol Res; 2018 Jul; 26(6):959-966. PubMed ID: 29295731
[TBL] [Abstract][Full Text] [Related]
23. [Associations between interleukin-17A expression and epithelial-mesenchymal transition in patients with hepatocellular carcinoma].
Xu J; Wang J; Hu Y; Cheng L; Yu H
Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):585-90. PubMed ID: 26714598
[TBL] [Abstract][Full Text] [Related]
24. Expression of E- and N-cadherin and clinicopathology in hepatocellular carcinoma.
Cho SB; Lee KH; Lee JH; Park SY; Lee WS; Park CH; Kim HS; Choi SK; Rew JS
Pathol Int; 2008 Oct; 58(10):635-42. PubMed ID: 18801083
[TBL] [Abstract][Full Text] [Related]
25. Altered distribution and expression pattern of E-cadherin in hepatocellular carcinomas: correlations with prognosis and clinical features.
Jiang XM; Zhang JB; Xiong J; Huang XX; Ren ZG
Asian Pac J Cancer Prev; 2012; 13(12):6455-61. PubMed ID: 23464474
[TBL] [Abstract][Full Text] [Related]
26. Loss of N-cadherin is associated with loss of E-cadherin expression and poor outcomes of liver resection in hepatocellular carcinoma.
Liu YA; Liang BY; Guan Y; You J; Zhu L; Chen XP; Huang ZY
J Surg Res; 2015 Mar; 194(1):167-76. PubMed ID: 25438959
[TBL] [Abstract][Full Text] [Related]
27. Activation of STAT3 signal pathway correlates with twist and E-cadherin expression in hepatocellular carcinoma and their clinical significance.
Zhang CH; Xu GL; Jia WD; Li JS; Ma JL; Ren WH; Ge YS; Yu JH; Liu WB; Wang W
J Surg Res; 2012 May; 174(1):120-9. PubMed ID: 21316706
[TBL] [Abstract][Full Text] [Related]
28. MTBP Promotes the Invasion and Metastasis of Hepatocellular Carcinoma by Enhancing the MDM2-Mediated Degradation of E-Cadherin.
Lu S; Zhou W; Wei H; He L; Li L
Dig Dis Sci; 2015 Dec; 60(12):3681-90. PubMed ID: 26280083
[TBL] [Abstract][Full Text] [Related]
29. NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2.
Chua HL; Bhat-Nakshatri P; Clare SE; Morimiya A; Badve S; Nakshatri H
Oncogene; 2007 Feb; 26(5):711-24. PubMed ID: 16862183
[TBL] [Abstract][Full Text] [Related]
30. Expression of E-cadherin and vascular endothelial growth factor in noncancerous liver is associated with recurrence of hepatocellular carcinoma after curative resection.
Minata M; Kudo M; Harada KH; Ikai I; Nishida N
Oncology; 2013; 84 Suppl 1():88-92. PubMed ID: 23428865
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of EphA2 and E-N cadherin switch in primary hepatocellular carcinoma.
Fan M; Liu Y; Xia F; Wang Z; Huang Y; Li J; Wang Z; Li X
Tumori; 2013; 99(6):689-96. PubMed ID: 24503792
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma.
Zha TZ; Hu BS; Yu HF; Tan YF; Zhang Y; Zhang K
Tumour Biol; 2012 Dec; 33(6):2125-34. PubMed ID: 22864671
[TBL] [Abstract][Full Text] [Related]
33. [Expression patterns of E-cadherin and beta-catenin according to clinicopathological characteristics of hepatocellular carcinoma].
Bae SH; Jung ES; Park YM; Jang JW; Choi JY; Cho SH; Yoon SK; Ahn BM; Cha SB; Chung KW; Sun HS; Park DH; Kim BK; Kim DG
Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):297-303. PubMed ID: 12499787
[TBL] [Abstract][Full Text] [Related]
34. Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition.
Hou KZ; Fu ZQ; Gong H
World J Gastroenterol; 2015 Jan; 21(2):475-83. PubMed ID: 25593462
[TBL] [Abstract][Full Text] [Related]
35. LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.
Yang H; Xiong FX; Lin M; Yang Y; Nie X; Zhou RL
J Cancer Res Clin Oncol; 2010 Feb; 136(2):275-81. PubMed ID: 19690886
[TBL] [Abstract][Full Text] [Related]
36. RARγ-induced E-cadherin downregulation promotes hepatocellular carcinoma invasion and metastasis.
Gan WJ; Wang JR; Zhu XL; He XS; Guo PD; Zhang S; Li XM; Li JM; Wu H
J Exp Clin Cancer Res; 2016 Oct; 35(1):164. PubMed ID: 27756432
[TBL] [Abstract][Full Text] [Related]
37. Six2 is negatively correlated with good prognosis and decreases 5-FU sensitivity via suppressing E-cadherin expression in hepatocellular carcinoma cells.
Li JW; Huang CZ; Li JH; Yuan JH; Chen QH; Zhang WF; Xu ZS; Liu YP; Li Y; Zhan MX; Lu LG
Biomed Pharmacother; 2018 Aug; 104():204-210. PubMed ID: 29772441
[TBL] [Abstract][Full Text] [Related]
38. Up-regulation of Twist induces angiogenesis and correlates with metastasis in hepatocellular carcinoma.
Niu RF; Zhang L; Xi GM; Wei XY; Yang Y; Shi YR; Hao XS
J Exp Clin Cancer Res; 2007 Sep; 26(3):385-94. PubMed ID: 17987801
[TBL] [Abstract][Full Text] [Related]
39. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway.
Zhang HG; Pan YW; Feng J; Zeng CT; Zhao XQ; Liang B; Zhang WW
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2003-2012. PubMed ID: 30915743
[TBL] [Abstract][Full Text] [Related]
40. The role of microRNA-200 in progression of human colorectal and breast cancer.
Bojmar L; Karlsson E; Ellegård S; Olsson H; Björnsson B; Hallböök O; Larsson M; Stål O; Sandström P
PLoS One; 2013; 8(12):e84815. PubMed ID: 24376848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
